Overall, individuals who developed dementia had lower baseline amyloid β42/40 and higher baseline levels of p-tau181, p-tau217, t-tau, NfL, and GFAP than those who did not develop all-cause and AD dementia. Here, GFAP is linked to Alzheimer disease.